Skip to search formSkip to main contentSkip to account menu

5-Fluorouracil/Salicylic Acid Topical Solution

Known as: Low-dose 5-Fluorouracil/Salicylic Acid 
A topical formulation containing 0.5 % of antimetabolite 5-fluorouracil (5-FU) and 10% of salicylic acid, with potential antimitotic and keratolytic… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Latar belakang masalah : Angka kejadian kanker colon semakin meningkat dan dengan perkembangan ilmu pengetahuan dibidang biologi… 
2004
2004
SummaryThe effect of acetazolamide (A.A.) on the antineoplastic activity of 1-phthalidyl 5-fluorouracil (PH-FU) against rat and… 
2003
2003
PURPOSE This study was performed to estimate the response rate and toxicity of a combination chemotherapy, which included… 
Review
2001
Review
2001
Colorectal cancer (CRC) is the second leading cause of cancer death in Western countries, and although the treatment of advanced… 
1998
1998
Doxorubicin-resistant metastatic breast cancer (MBC) is a very poor prognosis scenario, where only taxanes have shown activity… 
1987
1987
1. When 1-phthalidyl 5-fluorouracil (PH-FU) was incubated with isolated rat hepatocytes, 5-fluorouracil, 2-carboxybenzaldehyde… 
1984
1984
Bei 9 Patientinnen mit Mamma-Karzinom und Pleurakarzinosen, die im Rahmen des CMF-Schema 600 mg/m2 5-Fluorouracil i.v. erhielten… 
1976
1976
Twenty-one patients with disseminated colon carcinoma and clinically significant liver metastases were treated with 5-FUDR via… 
1959
1959
D e m o n s t r a t i o n b y Heidelberger et al. (8, 10) of the a n t i t u m o r activity" of 5-fluorouracil aga ins t a wide…